484 related articles for article (PubMed ID: 33166808)
1. Multicentric clinical and epidemiological comparison of neuromyelitis optica spectrum disorder with multiple sclerosis from India.
Gupta S; Rehani V; Acharya R; Purohit P; Anadure R; Ahmad F; Soni R; Gupta A; Hiremath R
Mult Scler Relat Disord; 2021 Jan; 47():102616. PubMed ID: 33166808
[TBL] [Abstract][Full Text] [Related]
2. Neuromyelitis optica spectrum disorders with a benign course. Analysis of 544 patients.
Lana-Peixoto MA; Talim NC; Callegaro D; Marques VD; Damasceno A; Becker J; Gonçalves MVM; Sato H;
Mult Scler Relat Disord; 2023 Jul; 75():104730. PubMed ID: 37156036
[TBL] [Abstract][Full Text] [Related]
3. Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder.
Nakamura Y; Liu Z; Fukumoto S; Shinoda K; Sakoda A; Matsushita T; Hayashida S; Isobe N; Watanabe M; Hiwatashi A; Yamasaki R; Kira JI
Eur J Neurol; 2020 Jan; 27(1):92-99. PubMed ID: 31304648
[TBL] [Abstract][Full Text] [Related]
4. Differential brainstem atrophy patterns in multiple sclerosis and neuromyelitis optica spectrum disorders.
Lee CY; Mak HK; Chiu PW; Chang HC; Barkhof F; Chan KH
J Magn Reson Imaging; 2018 Jun; 47(6):1601-1609. PubMed ID: 28990252
[TBL] [Abstract][Full Text] [Related]
5. Association of Optic Neuritis with Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis in Korea.
Kim H; Park KA; Oh SY; Min JH; Kim BJ
Korean J Ophthalmol; 2019 Feb; 33(1):82-90. PubMed ID: 30746915
[TBL] [Abstract][Full Text] [Related]
6. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
[TBL] [Abstract][Full Text] [Related]
8. Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort.
Edgar Patricio CD; Eleanor THG; Francisco José CZ; Gabriela ACM; Hyland AO; Fernando GL; María TA; Beatriz N; Marcos SD; Alfredo GPW
Mult Scler Relat Disord; 2020 Sep; 44():102208. PubMed ID: 32562910
[TBL] [Abstract][Full Text] [Related]
9. Validation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of South Indian patients.
Kanikannan MA; Arepareddy PK; Mathukumalli NL; Y S; Kandadai RM; Jabeen AS; T S; Borgohain R
Mult Scler Relat Disord; 2019 Oct; 35():164-169. PubMed ID: 31382202
[TBL] [Abstract][Full Text] [Related]
10. Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions.
Mealy MA; Mossburg SE; Kim SH; Messina S; Borisow N; Lopez-Gonzalez R; Ospina JP; Scheel M; Yeshokumar AK; Awad A; Leite MI; Arango JJ; Paul F; Palace J; Kim HJ; Levy M
Mult Scler Relat Disord; 2019 Feb; 28():64-68. PubMed ID: 30554040
[TBL] [Abstract][Full Text] [Related]
11. Elucidating distinct clinico-radiologic signatures in the borderland between neuromyelitis optica and multiple sclerosis.
Juryńczyk M; Klimiec-Moskal E; Kong Y; Hurley S; Messina S; Yeo T; Jenkinson M; Leite MI; Palace J
J Neurol; 2022 Jan; 269(1):269-279. PubMed ID: 34043042
[TBL] [Abstract][Full Text] [Related]
12. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing optic neuritis in neuromyelitis optica spectrum disease from multiple sclerosis: a novel magnetic resonance imaging scoring system.
Storoni M; Davagnanam I; Radon M; Siddiqui A; Plant GT
J Neuroophthalmol; 2013 Jun; 33(2):123-7. PubMed ID: 23609766
[TBL] [Abstract][Full Text] [Related]
14. Pediatric-onset multiple sclerosis in Brazilian patients: Clinical features, treatment response and comparison to pediatric neuromyelitis optica spectrum disorders.
Fragomeni MO; Bichuetti DB; Oliveira EML
Mult Scler Relat Disord; 2018 Oct; 25():138-142. PubMed ID: 30075406
[TBL] [Abstract][Full Text] [Related]
15. Differing Structural and Functional Patterns of Optic Nerve Damage in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.
Shen T; You Y; Arunachalam S; Fontes A; Liu S; Gupta V; Parratt J; Wang C; Barnett M; Barton J; Chitranshi N; Zhu L; Fraser CL; Graham SL; Klistorner A; Yiannikas C
Ophthalmology; 2019 Mar; 126(3):445-453. PubMed ID: 30060979
[TBL] [Abstract][Full Text] [Related]
16. Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American population.
Silveira F; Pappolla A; Sánchez F; Marques VD; de Castillo IS; Tkachuk V; Caride A; Castillo MC; Cristiano E; Cruz CA; Diégues Serva GB; Dos Santos AC; Moreira CL; López PA; Patrucco L; Molina O; Pettinicchi JP; Carnero Contentti E; Rojas JI
Mult Scler Relat Disord; 2020 Jul; 42():102049. PubMed ID: 32251869
[TBL] [Abstract][Full Text] [Related]
17. Fractional anisotropy helps to differentiate the optic nerve impairment between neuromyelitis optica spectrum disorders and multiple sclerosis.
Xie Y; Zhang Y; Yao Y; Liu D; Chen B; Zhu W
Eur Radiol; 2022 Sep; 32(9):6158-6166. PubMed ID: 35420298
[TBL] [Abstract][Full Text] [Related]
18. Epidemiologic and clinical characteristics of neuromyelitis optica spectrum disorder patients, A seven years follow-up study from Iran.
Ashtari F; Mehdipour R; Eini A; Ghalamkari A
Mult Scler Relat Disord; 2023 Sep; 77():104852. PubMed ID: 37399672
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic algorithm for relapsing acquired demyelinating syndromes in children.
Hacohen Y; Mankad K; Chong WK; Barkhof F; Vincent A; Lim M; Wassmer E; Ciccarelli O; Hemingway C
Neurology; 2017 Jul; 89(3):269-278. PubMed ID: 28615429
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological findings of neuromyelitis optica spectrum disorders in a Venezuelan study.
Ibis SC; Omaira M; Arnoldo S; Elizabeth A; Sandra M; Carlota CM; Elizabeth C; Laura V; Rosalba L; Oscar V; Luisa DM; Nahir A; Hernandez F
Mult Scler Relat Disord; 2021 Jan; 47():102652. PubMed ID: 33279797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
